Kyoto University Hospital says it will open a center to conduct clinical studies on induced pluripotent stem cell therapies in 2019 year.
Officials said the 30-bed ward will test the efficacy and safety of the therapies on volunteer patients.
The hospital aims to break ground at the site next February and complete construction by September 2019.
“As an iPS cell research hub, we hope to apply (the cells) to groundbreaking therapies and make developments in the field of drug discovery,” the hospital said in a statement Monday.
Ongoing research on iPS cells at Kyoto University includes turning the cells into dopamine-releasing neurons for transplant into patients with Parkinson’s disease, and creating a formulation of platelets that helps blood to clot.
Professor Shinya Yamanaka, who shared the 2012 Nobel Prize in medicine, leads the existing iPS cell research center at Kyoto University.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.